金猴数字化智能制鞋工厂只是威海高新区产业升级浪潮中一个缩影，同样深度发展智能化的还有威海君奥电气有限公司。企业自主研发工艺管理系统，同 步导入ERP系统，实现仓储环节数字化精准管理。 丛晓伟表示，高效的主控系统将智能机器人与MES系统深度联动，针对性破解了车间订单排产、任务跟踪、数据汇总等长期存在的痛点难题，真正实现 生产全流程可追溯、产品质量全周期有保障的智能化生产模式。 齐鲁晚报.齐鲁壹点记者田佳玉通讯员谢菁 帮脚刷处理剂机器人涂刷均匀无外溢、帮脚胶水机器人高速均匀刷胶……12月5日，在金猴集团威海鞋业有限公司数字化车间，高速运转的全自动生产线 上，11台机械臂围绕鞋坯灵活作业。而过去，这些环节高度依赖工人的手感和经验。 去年年末，金猴数字化智能制鞋工厂顺利完成试产。"我们联合意大利研发的胶粘类制鞋流水线，引入了国际顶尖的机械手、圆盘注射等智能设备，工作 人员只需在电脑中预设参数，机械臂即可精准完成帮脚打粗、涂胶等关键工序。"金猴集团鞋业公司设备部部长丛晓伟介绍，智能设备模拟人工操作手 法，不仅将单双鞋成型时间从20分钟压缩至4分钟，更实现人工成本降低30%以上、生产效率提升30%的成效。 "管理人员在办 ...

Core Viewpoint - The company plans to issue shares to acquire 100% equity of Shandong Weigao Puri Pharmaceutical Packaging Co., Ltd. from related parties, which constitutes a significant asset restructuring under regulatory guidelines [1] Group 1: Transaction Details - The transaction involves the acquisition of equity from Shandong Weigao Group Medical Polymer Co., Ltd., Weihe Shengxi Enterprise Management Consulting Center (Limited Partnership), and Weihe Ruiming Enterprise Management Consulting Partnership (Limited Partnership) [1] - This transaction is classified as a related party transaction and is subject to various approvals, including the board of directors, shareholders' meeting, Shanghai Stock Exchange, and China Securities Regulatory Commission [1] Group 2: Financial Status - As of the date of the announcement, the audit and evaluation of the target assets have not been completed, and the relevant financial data and transaction price are yet to be determined [1]

Group 1 - The stock price of Zhonghong Medical is reported at 15.95 yuan, down 0.01 yuan from the previous trading day, with a decline of 0.06% [1] - The opening price for the day was 16.10 yuan, reaching a high of 16.15 yuan and a low of 15.75 yuan, with a trading volume of 98,899 hands and a transaction amount of 1.57 billion yuan [1] - Zhonghong Medical operates in the medical device sector, focusing on the research, production, and sales of medical polymer products, including disposable sterile syringes and infusion devices [1] Group 2 - The subsidiary Shenzhen Maide Ruina recently obtained a medical device registration certificate for infusion pumps from the Guangdong Provincial Drug Administration [1] - The infusion pump is designed to be used with infusion lines for intravenous medication delivery, excluding analgesics, chemotherapy drugs, and insulin, and can also be used with enteral nutrition infusion lines for adjustable nutrient delivery [1] Group 3 - On August 22, the net outflow of main funds was 23.52 million yuan, accounting for 0.38% of the circulating market value [1] - Over the past five days, the cumulative net outflow of main funds reached 59.99 million yuan, representing 0.96% of the circulating market value [1]